arteriosclerosis therapy (Shinshu)

N/A

Report date: 2025/03/18 20:00:05

NME

Base Information

Drug Namearteriosclerosis therapy (Shinshu)

Drug Alias Nameoligonucleotides (Shinshu)

ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense

Mechanisms of ActionAntisense oligonucleotide inhibitorsSmooth muscle cell proliferation inhibitors

TargetsUpdating

Therapy Area/IndicationsArteriosclerosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesShinshu University

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsArteriosclerosis

ATC CodeN/A